Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WINDLAS | NSE
-22.90
-2.56%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
872.40
888.25
895.75
864.90
Windlas Biotech Limited contract development and manufacturing organization (CDMO) manufactures and trades in pharmaceutical products in India. It offers CDMO services including product discovery product development licensing and commercial manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands which include nutraceutical and health supplement products through the online and offline channels. In addition it manufactures pills capsules pouches sachets and liquid bottles; and generic products portfolio comprises fixed dosage combinations fixed dosage plus modified release combinations customized generics and chewable or dispersible. It exports its products primarily to Cambodia Ivory Coast the Philippines Thailand Vietnam Myanmar and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
41.2%1 month
38.9%3 months
46.5%6 months
47.3%31.83
-
4.17
0.01
0.01
18.24
2.66
-
795.44M
18.29B
218.74M
-
8.38
11.20
21.00
13.66
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
128.95
Range1M
165.55
Range3M
293.10
Rel. volume
0.46
Price X volume
22.55M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 737 | 14.78B | -4.72% | 15.67 | 0.18% |
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 127.88 | 13.43B | -2.66% | 17.47 | 10.32% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 46.62 | 10.75B | -2.59% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 405.85 | 10.74B | -1.04% | 53.99 | 4.77% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 383.15 | 10.70B | -4.01% | n/a | 119.57% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1479.35 | 8.44B | -0.14% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 253.35 | 8.30B | -1.11% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.79 | 8.14B | -1.82% | 2.10 | 1.78% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 370.4 | 5.99B | -1.71% | 50.24 | 17.95% |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 463.15 | 5.84B | -2.80% | 72.99 | 15.37% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 18.24 | - | Cheaper |
Ent. to Revenue | 2.66 | - | Cheaper |
PE Ratio | 31.83 | 47.84 | Cheaper |
Price to Book | 4.17 | 6.55 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 46.50 | - | Par |
Debt to Equity | 0.01 | 0.34 | Cheaper |
Debt to Assets | 0.01 | 0.17 | Cheaper |
Market Cap | 18.29B | - | Emerging |